0001140361-17-039390.txt : 20171024
0001140361-17-039390.hdr.sgml : 20171024
20171024152601
ACCESSION NUMBER: 0001140361-17-039390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171023
FILED AS OF DATE: 20171024
DATE AS OF CHANGE: 20171024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fuchs Charles S.
CENTRAL INDEX KEY: 0001719576
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 171150861
MAIL ADDRESS:
STREET 1: C/O CYTOMX THERAPEUTICS, INC.
STREET 2: 151 OYSTER POINT BLVD. SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2017-10-23
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001719576
Fuchs Charles S.
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD., STE. 400
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
20.04
2017-10-23
4
A
0
28000
0.00
A
2027-10-22
Common Stock
28000
28000
D
1/36th of the shares subject to the option vest on each monthly anniversary measured from October 23, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
/s/ Cynthia J. Ladd, as Attorney-in-Fact for Charles S. Fuchs
2017-10-24